Novo Nordisk-Backed Windward Bio Group Files for US IPO, Plans Nasdaq Listing Under 'WWB'

MT Newswires Live10-24

Novo Nordisk-backed (NVO) Windward Bio Group filed for an initial public offering of common shares in the US, according to a preliminary prospectus filed with the US Securities and Exchange Commission on Friday.

The company has applied to list the shares on the Nasdaq Global Market under the symbol "WWB," the filing said. The offering will not be completed if the listing application is not approved.

The filing did not disclose the number of shares or the expected price range. Underwriters have a 30-day option to buy additional shares from the company.

Jefferies, TD Cowen, Piper Sandler and UBS Investment Bank are the underwriters, according to the filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment